Indrojit Roy1, Emmanuel Othieno. 1. Department of Pathology, St Mary’s Hospital, McGill University, Montreal, Canada. indrojit.roy@ssss.gouv.qc.ca
Abstract
CONTEXT: Histologic and receptor data on breast carcinoma in Uganda are scarce. Estrogen receptor status is not routinely available. Breast cancer blocks from Uganda were studied in Montreal, Canada, and clinical correlations subsequently discussed in Kampala, Uganda. OBJECTIVE: To correlate histologic features (tumor type, histologic grade), receptor profile (estrogen receptor, progesterone receptor, and HER2/neu), and age in Ugandan women. DESIGN: Pathology reports for 2000-2004 from Nsambya Hospital, reporting invasive breast carcinoma, provided 45 microscopically confirmed cases. RESULTS: Seventy-three percent of patients were 50 years or younger. Histologic types were invasive ductal carcinoma (78%) and "good" prognosis types (11%). Overall 40% were grade 3, but 48% of invasive ductal carcinomas were grade 3. Estrogen receptor was positive in 60% overall and in 51% of invasive ductal carcinomas. HER2/neu was overexpressed in 11%; 36% were "triple" negative (estrogen receptor, progesterone receptor, HER2/neu negative). CONCLUSIONS: Breast carcinoma in Ugandan women presents at a younger age and is histologically and by receptor profile more aggressive than carcinoma in Caucasian women.
CONTEXT: Histologic and receptor data on breast carcinoma in Uganda are scarce. Estrogen receptor status is not routinely available. Breast cancer blocks from Uganda were studied in Montreal, Canada, and clinical correlations subsequently discussed in Kampala, Uganda. OBJECTIVE: To correlate histologic features (tumor type, histologic grade), receptor profile (estrogen receptor, progesterone receptor, and HER2/neu), and age in Ugandan women. DESIGN: Pathology reports for 2000-2004 from Nsambya Hospital, reporting invasive breast carcinoma, provided 45 microscopically confirmed cases. RESULTS: Seventy-three percent of patients were 50 years or younger. Histologic types were invasive ductal carcinoma (78%) and "good" prognosis types (11%). Overall 40% were grade 3, but 48% of invasive ductal carcinomas were grade 3. Estrogen receptor was positive in 60% overall and in 51% of invasive ductal carcinomas. HER2/neu was overexpressed in 11%; 36% were "triple" negative (estrogen receptor, progesterone receptor, HER2/neu negative). CONCLUSIONS:Breast carcinoma in Ugandan women presents at a younger age and is histologically and by receptor profile more aggressive than carcinoma in Caucasian women.
Authors: Eva Johanna Kantelhardt; Assefa Mathewos; Abreha Aynalem; Tigeneh Wondemagegnehu; Ahmedin Jemal; Martina Vetter; Erdme Knauf; Anne Reeler; Solomon Bogale; Christoph Thomssen; Andreas Stang; Tufa Gemechu; Pietro Trocchi; Bekuretsion Yonas Journal: BMC Cancer Date: 2014-11-29 Impact factor: 4.430
Authors: Rispah T Sawe; Simeon K Mining; Ayub V Ofulla; Kirtika Patel; Bernard Guyah; David Chumba; Jenifer R Prosperi; Maggie Kerper; Zonggao Shi; Mayra Sandoval-Cooper; Katherine Taylor; Sunil Badve; M Sharon Stack; Laurie E Littlepage Journal: Trop Med Health Date: 2017-08-04
Authors: Marianne Gnanamuttupulle; Oliver Henke; Shilanaiman Hilary Ntundu; Furaha Serventi; Leila E Mwakipunda; Patrick Amsi; Alex Mremi; Kondo Chilonga; David Msuya; Samuel G Chugulu Journal: Ecancermedicalscience Date: 2021-09-07
Authors: Gertrude Luyeye Mvila; Sandra Postema; Guy Marchal; Erik Van Limbergen; Fons Verdonck; Gert Matthijs; Koen Devriendt; Genevieve Michils; Chantal Van Ongeval Journal: BMC Public Health Date: 2014-07-28 Impact factor: 3.295